🔥🐔 BizChicken 🐔🔥
Companies Similar to Synaptogenix, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Alector, Inc.
AL001, AL101, AL002, AL003, AL044
Alector, Inc. is a clinical stage biopharmaceutical company focused on developing therapies for neurodegeneration diseases. The company has several products in various stages of clinical trials aimed at treating conditions such as Alzheimer's, Parkinson's, and frontotemporal dementia.
About | Vision/Values | History | Leadership | Contact | Culture | Vision/Values | History | About | About | About | About | Careers | About | About
Symbol: ALEC
Recent Price: $1.72
Industry: Biotechnology
CEO: Dr. Arnon Rosenthal Ph.D.
Sector: Healthcare
Employees: 245
Address: 131 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 415 231 5660
Leadership
- Arnon Rosenthal, Ph.D., Co-Founder, Chief Executive Officer, and Director
- Sara Kenkare-Mitra, Ph.D., President and Head of Research and Development
- Marc Grasso, M.D., Chief Financial Officer
- Gary Romano, M.D., Ph.D., Chief Medical Officer
- Danielle Pasqualone, Ph.D., J.D., General Counsel
- Clare Hunt, M.B.A., Chief People Officer
- Kristina Cutter, M.P.H., Chief Regulatory, Pharmacovigilance, and Quality Assurance Officer
- Virginia DeJesus-Rueff, M.B.A., Chief of Staff and Head of Strategy
- Norah Conway, Senior Vice President, Portfolio and Program Management
- Neil Berkley, M.S., M.B.A., Chief Business Officer
- Louis J. Lavigne Jr., M.B.A., Chairperson of the Board
- Elizabeth Garofalo, M.D., Board Member
- Paula Hammond, Ph.D., Board Member
- Richard H. Scheller, Ph.D., Board Member
- David Wehner, Board Member
- Kristine Yaffe, M.D., Board Member
- Errol De Souza, Ph.D., Board Member
- Mark Altmeyer, M.B.A., Board Member
Last updated: 2024-12-31
Biogen Inc.
TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, FAMPYRA, SPINRAZA, FUMADERM, BENEPALI, ADUHELM, IMRALDI, FLIXABI, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS
Biogen Inc. focuses on discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, plaque psoriasis, Alzheimer's disease, and various cancers and autoimmune conditions.
About | About | Vision/Values | Leadership | Foundation | Contact | Careers | Careers | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Benefits | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: BIIB
Recent Price: $150.19
Industry: Drug Manufacturers - General
CEO: Mr. Christopher A. Viehbacher
Sector: Healthcare
Employees: 7570
Address: 225 Binney Street, Cambridge, MA 02142
Phone: 617 679 2000
Leadership
- Christopher A. Viehbacher, President and Chief Executive Officer
- Susan H. Alexander, Chief Legal Officer
- Ginger Gregory, Ph.D., Chief Human Resources Officer
- Jane Grogan, Ph.D., Head of Research
- Rachid Izzar, Head of Global Product Strategy & Commercialization
- Adam Keeney, Head of Corporate Development
- Michael McDonnell, Chief Financial Officer
- Nicole Murphy, Head of Pharmaceutical Operations and Technology
- Priya Singhal, M.D., M.P.H., Head of Development and Interim Chief Medical Officer
- Alisha Alaimo, President, Head of North America
- Stephen Amato, Head of Investor Relations
- Natacha Gassenbach, Head of Corporate Affairs, Chief Communications Officer
- Fraser Hall, President, Head of Intercontinental Region
- Wolfram Schmidt, President, Head of Europe
- Kendra Thomas, Head of Global Workforce Diversity, Equity & Inclusion (DE&I)
- Caroline Dorsa, Chair of the Board
- Maria C. Freire, Ph.D., Director
- William A. Hawkins, Director
- Susan Langer, Director
- Jesus B. Mantas, Director
- Lloyd B. Minor, M.D., Director
- Monish Patolawala, Director
- Eric K. Rowinsky, M.D., Director
- Stephen A. Sherwin, M.D., Director
Last updated: 2024-12-31
Athira Pharma, Inc.
ATH-1017
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.
Symbol: ATHA
Recent Price: $0.55
Industry: Biotechnology
CEO: Dr. Mark J. Litton M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 18706 North Creek Parkway, Bothell, WA 98011
Phone: 425 620 8501
Last updated: 2024-12-31
CNS Pharmaceuticals, Inc.
Berubicin
CNS Pharmaceuticals, Inc. is a clinical pharmaceutical company focused on developing anti-cancer drugs for brain and central nervous system tumors. Their lead drug candidate, Berubicin, targets glioblastoma multiforme through clinical trials and partnerships with notable institutions.
Symbol: CNSP
Recent Price: $0.11
Industry: Biotechnology
CEO: Mr. John Michael Climaco Esq., J.D.
Sector: Healthcare
Employees: 3
Address: 2100 West Loop South, Houston, TX 77027
Phone: 800 946 9185
Last updated: 2024-12-31
Cyclerion Therapeutics, Inc.
CY6463
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious CNS diseases, with products like CY6463 for mitochondrial encephalomyopathy and Alzheimer's disease.
Symbol: CYCN
Recent Price: $3.45
Industry: Biotechnology
CEO: Dr. Regina Graul Ph.D.
Sector: Healthcare
Employees: 1
Address: 245 First Street, Cambridge, MA 02142
Phone: 857 327 8778
Last updated: 2024-12-31
Inhibrx Biosciences, Inc.
Therapeutic Candidates (INBRX-109, INBRX-106)
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops biologic therapeutics for life-threatening conditions, with therapeutic candidates in phase 2 clinical trials targeting various cancers.
Symbol: INBX
Recent Price: $15.14
Industry: Biotechnology
CEO: Mr. Mark Paul Lappe
Sector: Healthcare
Employees: 166
Address: 11025 North Torrey Pines Road, La Jolla, CA 92037
Phone: 858-795-4220
Last updated: 2024-12-31
Supernus Pharmaceuticals, Inc.
Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC
Supernus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system diseases, including epilepsy, migraine, ADHD, and Parkinson's Disease.
Symbol: SUPN
Recent Price: $36.91
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Jack A. Khattar M.B.A.
Sector: Healthcare
Employees: 652
Address: 9715 Key West Avenue, Rockville, MD 20850
Phone: 301 838 2500
Last updated: 2024-12-31
Alto Neuroscience, Inc.
ALTO-100, ALTO-300, ALTO-101, ALTO-203, ALTO-202
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company specializing in psychiatry drug development, with a range of innovative treatments targeting major depressive disorder and cognitive impairments.
Symbol: ANRO
Recent Price: $4.20
Industry: Biotechnology
CEO: Dr. Amit Etkin M.D., Ph.D.
Sector: Healthcare
Employees: 78
Address: 369 South San Antonio Road, Los Altos, CA 94022
Phone: (650) 200-0412
Last updated: 2024-12-31
Alzamend Neuro, Inc.
AL001 and AL002
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing products for neurodegenerative and psychiatric disorders. Their pipeline includes AL001 for Alzheimer's and psychiatric disorders, and AL002 for Alzheimer's disease using a novel vaccine approach.
About | About | Contact | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: ALZN
Recent Price: $1.20
Industry: Biotechnology
CEO: Mr. Stephan Jackman
Sector: Healthcare
Employees: 4
Address: 3500 Lenox Road NE, Atlanta, GA 30326
Phone: 844 722 6333
Last updated: 2024-12-31
Amylyx Pharmaceuticals, Inc.
AMX0035
Amylyx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Their leading product, AMX0035, is aimed at ALS treatment.
About | Leadership | Directors | Contact | Careers | About | About | About | About | About | About | About | About | News | About
Symbol: AMLX
Recent Price: $3.84
Industry: Biotechnology
CEO: Mr. Joshua B. Cohen
Sector: Healthcare
Employees: 384
Address: 43 Thorndike Street, Cambridge, MA 02141
Phone: 617 682 0917
Leadership
- Linda A. Arsenault, Chief Human Resources Officer
- Camille L. Bedrosian, MD, Chief Medical Officer
- Josh Cohen, Co-CEO & Co-Founder
- James M. Frates, Chief Financial Officer
- Tom Holmes, Chief Technical Operations Officer
- Justin Klee, Co-CEO & Co-Founder
- Gina M. Mazzariello, Chief Legal Officer & General Counsel
- Rudolph Tanzi, PhD, Founding Chair of the Amylyx SAB
- Wally Gilbert, Special Advisor
- Kari Firestone, Director
- Paul Fonteyne, Director
- George Milne, Chairman
- Daphne Quimi, Director
- Bernhardt G. Zeiher, MD, FACP, FCCP, Director
Last updated: 2024-12-31
Anavex Life Sciences Corp.
ANAVEX 2-73
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company developing drug candidates for CNS diseases, including Alzheimer's, Rett syndrome, and Parkinson's.
Symbol: AVXL
Recent Price: $11.04
Industry: Biotechnology
CEO: Dr. Christopher U. Missling M.B.A., M.S., Ph.D.
Sector: Healthcare
Employees: 40
Address: 51 West 52nd Street, New York, NY 10019
Phone: 844 689 3939
Last updated: 2024-12-31
NeuroBo Pharmaceuticals, Inc.
ANA001
A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.
Symbol: NRBO
Recent Price: $2.36
Industry: Biotechnology
CEO: Mr. Hyung-Heon Kim
Sector: Healthcare
Employees: 8
Address: 200 Berkeley Street, Boston, MA 02116
Phone: 857 702 9600
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Protagenic Therapeutics, Inc.
PT00114
Protagenic Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing therapeutics for stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, aims to regulate stress response and restore healthy brain function.
Symbol: PTIX
Recent Price: $0.54
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 1
Address: 149 Fifth Avenue, New York, NY 10010
Phone: 212 994 8200
Last updated: 2024-12-31
Soligenix, Inc.
SGX301 (Hy Bryte), SGX942, SGX203, SGX302
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases, operating in the Specialized Bio Therapeutics and Public Health Solutions segments.
About | Directors | About | About | About | About | About | About | Contact | About | About | About | About | About | Careers | Careers | About | About | About | About | About | About | About
Symbol: SNGX
Recent Price: $2.91
Industry: Biotechnology
CEO: Dr. Christopher J. Schaber Ph.D.
Sector: Healthcare
Employees: 13
Address: 29 Emmons Drive, Princeton, NJ 08540
Phone: 609 538 8200
Leadership
- Christopher J. Schaber, PhD, Chairman, President and Chief Executive Officer
- Gregg A. Lapointe, CPA, MBA, Board Director
- Diane L. Parks, MBA, Board Director
- Robert J. Rubin, MD, Board Director
- Jerome Zeldis, MD, PhD, Board Director
Last updated: 2024-12-31
Synaptogenix, Inc.
Bryostatin-1
Synaptogenix, Inc. is a biopharmaceutical company focused on developing drug candidates for neurodegenerative diseases, including Alzheimer's disease, using Bryostatin-1.
Symbol: SNPX
Recent Price: $3.37
Industry: Biotechnology
CEO: Dr. Alan J. Tuchman M.D., MBA(FAAN)
Sector: Healthcare
Employees: 5
Address: 1185 Avenue of the Americas, New York, NY 10036
Phone: 973 242 0005
Last updated: 2024-12-31
Synlogic, Inc.
Synthetic Biotic Medicines
Synlogic, Inc. is a clinical-stage biopharmaceutical company focused on the development of synthetic biotic medicines to treat metabolic and immunological diseases. The company's pipeline includes drug candidates for conditions such as phenylketonuria, homocystinuria, enteric hyperoxaluria, and solid tumors and lymphoma.
Symbol: SYBX
Recent Price: $1.40
Industry: Biotechnology
CEO: Mr. Antoine Awad
Sector: Healthcare
Employees: 6
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 617 401 9975
Last updated: 2024-12-31
Annovis Bio, Inc.
Buntanetap
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound, Buntanetap, is in clinical trials for various neurodegenerative disorders.
Symbol: ANVS
Recent Price: $5.08
Industry: Biotechnology
CEO: Dr. Maria L. Maccecchini Ph.D.
Sector: Healthcare
Employees: 6
Address: 1055 Westlakes Drive, Berwyn, PA 19312
Phone: 610 727 3913
Last updated: 2024-12-31
Synaptics Incorporated
Semiconductor Product Solutions
Synaptics Incorporated develops and sells semiconductor solutions, including audio processing, data connectivity, video transmission, and fingerprint detection technologies.
About | News | About | Events | About | ESG | About | Contact | Contact | Careers | Jobs | About | About
Symbol: SYNA
Recent Price: $75.50
Industry: Semiconductors
CEO: Mr. Michael E. Hurlston
Sector: Technology
Employees: 1716
Address: 1109 McKay Drive, San Jose, CA 95131
Phone: 408 904 1100
Last updated: 2024-12-31
Crinetics Pharmaceuticals, Inc.
Paltusotine
Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on discovering, developing, and commercializing therapeutics for rare endocrine diseases and related tumors. Their leading product candidate, Paltusotine, has completed phase III trials for acromegaly treatment.
About | About | About | Contact | Contact | About | About | Culture | Culture | Careers | Jobs | Benefits | Jobs | Careers | Careers | Careers | About | About | About | About | About | About | About | About | About | About | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Careers | Vision/Values | Careers | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Jobs | Careers | Culture | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About | About | About | Careers | Careers
Symbol: CRNX
Recent Price: $50.67
Industry: Biotechnology
CEO: Dr. R. Scott Struthers Ph.D.
Sector: Healthcare
Employees: 290
Address: Building No. 2, San Diego, CA 92121
Phone: 858 450 6464
Last updated: 2024-12-31